secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000950170-23-000442
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical beats FY22 revenue guidance; Q4 revenue up ~47-48% YoY
---------------------------------------------------------------------

- Preliminary Q4 2022 revenue $49.1M-$49.6M, up 47-48% YoY.
- Preliminary FY22 revenue $141.2M-$141.7M, up ~50% YoY, above prior guidance of $135M-$138M.
- CEO cites strength of direct sales channel, DTC programs, and R&D investments.
- Company plans to provide 2023 guidance on Q4 earnings call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023000442/0000950170-23-000442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017023000442/tmci-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer